Behavioral help for adult smokers with poor sleep to quit smoking
Tests a behavioral program and varenicline for smokers with insomnia trying to quit.
Key facts
- Who runs it
- Yale University
- Where
- New Haven, United StatesSee the 2 sites
- Trial code
- Registry title
- Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 114 people, planned
- Started
- 21 Apr 2025
- Expected to end
- Jun 2029
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Experimental health intervention
- Varenicline
- Record updated
- 5 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who use a lot of tobacco or nicotine e-cigarettes and want to quit. It tests whether a behavioral program helps people quit by easing negative feelings and improving self-control.
- Age
- 18 Years to 65 Years
- Sex
- All sexes can join.
- Disease stage
- Heavy tobacco use, including nicotine e-cigarettes, for more than 6 months. A test must show recent cigarette smoking or e-cigarette use. People must be able to read English and have a body mass index in the range the trial calls optimal.
- Earlier treatment
- People who are currently enrolled in other treatments cannot join.
- Biomarker or test result
- A biochemical test result showing recent cigarette smoking or e-cigarette use.
Main reasons for not taking part
- Currently enrolled in other treatments
- Brain or mental health conditions that could get in the way of the study, raise risk, or cause poor sleep
- Medical reasons that rule out fMRI brain scans, varenicline or the behavioral treatment
- Other causes of poor sleep for which the behavioral treatment helps less
- Being pregnant or breastfeeding
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- English literate
- report heavy tobacco use (including nicotine e-cigarettes) for >6 months
- meet biochemical cut off for recent cigarette smoking or e-cigarette use
- optimal body mass index
Who cannot take part
- currently enrolled in other treatments
- neuropsychiatric exclusions that could interfere with study participation, increase risk of adverse events, and/or induce deficient sleep
- medical contraindications for fMRI, varenicline, and/or behavioral treatment
- factors that cause deficient sleep and for which behavioral treatment has less benefit
- women who are pregnant or nursing
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Where in United States
- Connecticut Mental Health CenterNew Haven, United StatesContact: Yu Chen, PhDTaking people
- Yale UniversityNew Haven, United StatesContact: Yu Chen, PhDTaking people
About the trial
What the trial wants to find out
The study aims to investigate whether behavioral interventions promote cessation in adult smokers by ameliorating negative emotions and improving self-control and identify the neural markers of these effects.
The 2 groups in the trial
- Experimental health interventionTreatment being tested
Experimental health intervention and varenicline starting 4 weeks before and continuing for 4 weeks after a target quit date for a total of 8 weeks
Treatment: Experimental health intervention and Varenicline
- Control health interventionExisting treatment, for comparison
Control health intervention and varenicline starting 4 weeks before and continuing for 4 weeks after a target quit date for a total of 8 weeks
Treatment: Varenicline
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse
- Plain-language title
- Behavioral help for adult smokers with poor sleep to quit smokingGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT06609369, who can take part
- Record updated
- 5 June 2026